Stay updated on Magrolimab Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in AML Clinical Trial page.

Latest updates to the Magrolimab Combo in AML Clinical Trial page
- Check6 days agoChange DetectedNew user guidance sections were added and a recruitment status line indicates that enrollment has ended. The Intervention/Treatment header formatting was updated and a site revision note (Revision: v3.6.0) was added.SummaryDifference0.2%

- Check13 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new release of the page content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision indicator updated from v3.5.3 to v3.5.4, representing a new build of the page. This reflects a small version update of the page rather than a content change.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page’s footer revision version was updated from v3.5.2 to v3.5.3, indicating a maintenance or release update without changing the clinical study details.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision: v3.5.0. The update appears to be a platform version bump with no changes to the trial details or essential content.SummaryDifference0.0%

Stay in the know with updates to Magrolimab Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in AML Clinical Trial page.